Artificial Intelligence in Medicine Market - Overview
Artificial intelligence (AI) has the potential to revolutionize any piece of work that can be operated via binary commands and has a finite set of possibilities. The concept of AI is currently being harnessed furiously, and the forever flourishing field of health care is leveraging it to attain greater goods for humanity. Now, artificial intelligence is touching almost every field of concern such as business, translation, advertising, photography, and many more. Artificial intelligence is also significantly being used in the health care sector. Currently, medical artificial intelligence has been adopting various computer aided technologies to perform clinical diagnoses and suggest treatments. AI has the capability of detecting meaningful relationships in a data set and has been widely used in many clinical situations to diagnose, treat, and predict results.
Artificial Intelligence in Medicine Market – Trends and Opportunities
Furthermore, the application of artificial intelligence (AI) techniques to medical problems has been a goal of computing since the development of high-speed digital computers. Going forward, AI is estimated to aid not only in diagnosis procedures but also in drug development, devising personalized medicine, and closely monitoring patients. A large number of pioneering technology vendors are currently involved in developing AI algorithms for the health care sector. Furthermore, the importance of computer-aided medical education is estimated to increase in the coming years. Medical educators, rather than computer scientists, are taking the lead in this selection process. Aided by careful studies, they are identifying deficiencies in the current (non-computerized) medical education process.
Artificial intelligence companies are growing at a much faster rate than expected. Technological giants in artificial intelligence such as Apple, Microsoft, Tesla, Google, etc. have predicted AI to be the technology of the future. Even these companies are surprised by the rapid growth of artificial intelligence. Furthermore, investment in AI has increased to over six times in the past few years. Organizations are investing heavily in AI companies. This has sped up the research work process in the field of AI. Companies are now able to hire more resources, and this is one of the main reasons for the growth of AI companies. Business intelligence and analytics have also improved to a great extent, which is also important for the growth of AI companies. Additionally, growing importance of precision medicine, increase in the number of cross-industry collaborations, consistent inflow of venture capital investments, and a rise in the geriatric population are some of the other factors that are expected to drive the artificial intelligence in medicine market. Also, development of medical artificial intelligence has been related to the development of AI programs intended to help clinicians in the formulation of a diagnosis, the making of therapeutic decisions, and the prediction of outcomes. They are designed to support health care workers in their everyday duties, assisting with tasks that rely on the manipulation of data and knowledge. On the other hand, reluctance of medical practitioners in adopting new technologies, strong lack of a preset and universal regulatory guidelines, lack of curated health care data, and concerns of data privacy are anticipated to hinder the artificial intelligence in medicine Market in the next few years. The adoption of artificial intelligence in medicine in European countries such as the U.K., Germany, etc. is expected to offer opportunities to the artificial intelligence in medicine market in the near future.
Artificial Intelligence in Medicine Market – Segmentation
The artificial intelligence in medicine market can be segmented based on technology, application, component, and region. In terms of technology, the artificial intelligence in medicine market can be classified into querying method, deep learning, context aware processing, and natural language processing. Based on application, the artificial intelligence in medicine market can be categorized into virtual assistant, research and drug discovery, medical imaging and diagnosis, precision medicine, clinical research trial, and personalized medicine. In terms of component, the artificial intelligence in medicine market can be classified into hardware, software, and services.
Based on region, the artificial intelligence in medicine market can be segmented into North America, Europe, Asia Pacific, Middle East & Africa and South America. North America dominates the global artificial intelligence in medicine market. The region’s supremacy has been facilitated by the presence of numerous key industry players, particularly in the U.S., who have joined hands to offer advanced solutions to customers in the health care industry.
Artificial Intelligence in Medicine Market – Key Players
Major vendors operating in the artificial intelligence in medicine market are Welltok, Inc., Intel Corporation, Nvidia Corporation, Google Inc., IBM Corporation, Microsoft Corporation, General Vision, Inc., Enlitic, Inc., BioXcel Corporation, and Berg Health. Other prominent players in the value chain include InSilico Medicine, Inc., Globavir Biosciences, Inc., GNS Healthcare, Flatiron Health, Benevolent AI, Atomwise, Verge Genomics, Cloud Pharmaceuticals, and Recursion Pharmaceuticals.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.